Company News
Strides Pharma Q2 FY27 Earnings Call Announcement
Strides Pharma schedules earnings call on October 30, 2026, to discuss Q2 and H1 FY27 unaudited financial results.
Senior management including MD & Group CEO Badree Komandur and Group CFO Vikesh Kumar
